Navigation Links
Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting
Date:9/14/2009

toring in HF patients: Results of the FAST trial. This trial focused on comparing the relative sensitivity and unexplained detection rate of changes in daily weights vs. intrathoracic impedance changes. The trial concluded that the sensitivity and unexplained detection rate of an intrathoracic fluid index were superior to those for acute weight changes in HF patients with implantable devices. Intrathoracic impedance monitoring represents a positive addition to our armamentarium for managing HF and should be considered for routine use in patients with implanted devices with this feature in addition to daily weight monitoring.
  • Effects of rolofylline, a selective adenosine A1 receptor antagonist, in patients hospitalized for acute decompensated heart failure and renal impairment: Findings from the PROTECT study. This trial was designed to test the hypothesis that the selective A1 adenosine receptor antagonist rolofylline would safely improve HF signs and symptoms, reduce the risk of worsening renal function and reduce morbidity and mortality when used with IV loop diuretics in subjects with ADHF, volume overload and renal impairment. Surprisingly and disappointedly, rolofylline was not associated with an improvement in the primary endpoint or the two secondary endpoints including renal function. This trial, the largest to date in ADHF, will require further analysis to help investigators develop new strategies for the important but complicated condition of ADHF.
  • "Each year we discover new and innovative treatments for patients living with heart failure," said Dr. Douglas Mann, HFSA President. "It is important for the medical community to continue to utilize science and clinical medicine to improve care that we provide to patients with heart failure."

    For a complete list of annual meeting sessions or for details on attending the conference, call (617) 226-7183 or visit '/>"/>

    SOURCE The Heart Failure Society of America
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
    2. MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
    3. UNT Health Science Centers Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
    4. Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
    5. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
    6. Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
    7. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
    8. Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study
    9. Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting
    10. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
    11. Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstCa...mpanymanufacturingpoint-of-carebloodanalysissystem...executiveofficer,willpresentatthe21stAnnualPiperJa...9at2:00p.m.ET.TheconferencewillbeheldattheNewYorkP... Abaxisdevelops,manufacturesandmarketsportablebloo...
    (Date:11/25/2009)...,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cempra...rnandes,presidentandchiefexecutiveofficer,willpres...at8:50a.m.EST,December1,2009,atTheNewYorkPalaceHot...fthecompany,stwoleadingantibioticclinicalprogramsf...SA. ,, AboutCempraPharmaceuticals ,, Found...
    (Date:11/25/2009)...,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswir...HTWR ;ASX:HIN),aleadinginnovatorandprovideroflessi...revolutionizingthetreatmentofadvancedheartfailure,...sentationatthe21stAnnualPiperJaffrayHealthCareConf...ferenceisbeingheldattheNewYorkPalaceHotel,December...
    Breaking Medicine Technology:WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference 6355 1Need for emergency airway surgery for hard to intubate patients reduced 61570 1Need for emergency airway surgery for hard to intubate patients reduced 61570 2Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 1Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 2Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 3
    ... EVEN MORE SCIENCE SUPPORTING THE, THEORY THAT VA... A primate model for autism,using the U.S. childr...ernational Meeting For Autism Research (IMFAR) thi...eed for studies into vaccine safety and,the immune...n. The National,Autism Association (NAA) questions...
    ...rapeutics present preliminary Phase II data ...ated and mechanically-ventilate...lthCare,together with Nektar Therapeutics (Nasdaq:...se II data on their unique drug-device combination...(ATS) annual meeting. Amikacin,Inhale, currently b...
    Other Medicine Technology:UPDATE: Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Behavioral Symptoms of Autism 2Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7
    (Date:11/25/2009)...ASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConven...edicalcliniconDec.9-10,whenKansasCityhoststhelates...,, "Thisfreecliniceventhasthepotentialtobethebi...fjustoneandbeheldonweekdaysinsteadofoveraweekend,"...thClinicandpresidentoftheNationalAssociationofFree...
    (Date:11/25/2009)...NTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...ationsoftwarelaunchesasuiteofnewleadingedgeclinica...latformatthisyear,sRadiologicalSocietyofNorthAmeri...ooth5800,HallA).Theapplicationsleveragetheuniquehi...RIimagingcoilsandsupportmultipleimagingmodalitiesf...
    (Date:11/25/2009)...NGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAIDS...ermineexecutiveleadershipfor2010. ,, ThenewBoar...tiesinpublicpolicy,law,finance,governmenthealthpro...rdalsocomesfromawiderangeofpersonalbackgroundsincl...vingwithHIVthemselves,andrepresentingmultipleagegr...
    (Date:11/25/2009)...survivors of testicular cancer who were treated wi...de effects, including neurological side effects an...eated with chemotherapy, according to a new study ...e National Cancer Institute . , Marianne Brydy, ...versity Hospital, in Bergen, Norway, and colleague...
    (Date:11/25/2009)...s increase blood pressure? This simple question h...rs. New Stress-related gene Modulates High Blood ...d pressure? This simple question has been the foc...search has for the first time established a link b...sure response to stress in mice as well as humans....
    Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
    ...q: UCNN ), the market leader in on-demand contac... agreement for inContact(R) with a leading,healthc...000 members across 13,markets. , This new cu...locations. They chose the inContact platform to re...
    ..., Inc. and EF,Recovery announced today that they h...ire Chief,s Fire Rescue Wellness Corporation to br...shington area firefighters. , "The health an...pidemic of overweight and obesity that affects mor...
    ...hit television,show ,Living in Style, will highlig...CLA. ,Living in Style, is a half-hour news magazin...of Clarinol(TM) CLA, with its clinically,proven ab... consumer and utilizes Clarinol(TM) CLA in its Hea...
    ... middle of,separation or divorce often face Thanks...ily traditions are shattered; the hope and joy tha...neliness and depression. This year,s,economic down... international network of divorce recovery support...
    ...nt comfort gaining,momentum, hospitals and healthc...nsider patients, relief and welfare. This is leadi...agement systems, which are being used for a greate...rost & Sullivan ( http://www.medicaldevices.fr...
    ...hborhood with highest citywide rate of diabetes ho...n World Diabetes Day, St. Anthony Free Medical Cli...s well as diabetic foot and eye exams, medication ...f diabetes in San Francisco,s Tenderloin district ...
    Other Medicine News:Health News:Leading Healthcare Provider Signs Agreement With UCN for inContact 2Health News:Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness 2Health News:Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness 3Health News:Clarinol(TM) CLA and Puregels(R) Featured on Hit Television Show 'Living in Style' 2Health News:Clarinol(TM) CLA and Puregels(R) Featured on Hit Television Show 'Living in Style' 3Health News:Holiday Season Amplifies Hurt of Separation and Divorce: Economic Woes Add to Pressure 2Health News:Patient Temperature Management Systems Enjoying Wider Usage 2Health News:Patient Temperature Management Systems Enjoying Wider Usage 3Health News:Turkey Tips, Massage, and a Blood Test: St. Anthony's Celebrates Diabetes Day in New Green Clinic 2
    ... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
    ... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
    ... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
    ... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
    Medicine Products: